Psychemedics Corporation (PMD)
Psychemedics Statistics
Share Statistics
Psychemedics has 5.89M shares outstanding. The number of shares has increased by 1.6% in one year.
| Shares Outstanding | 5.89M |
| Shares Change (YoY) | 1.6% |
| Shares Change (QoQ) | 1.21% |
| Owned by Institutions (%) | 20.9% |
| Shares Floating | 4.31M |
| Failed to Deliver (FTD) Shares | 109 |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 13.85K, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 13.85K |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 0.79 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is null. Psychemedics's PEG ratio is undefined.
| PE Ratio | undefined |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| Forward PS | null |
| PB Ratio | 2.55 |
| P/FCF Ratio | undefined |
| PEG Ratio | undefined |
Enterprise Valuation
Psychemedics has an Enterprise Value (EV) of 17.32M.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of undefined.
| Current Ratio | 1.45 |
| Quick Ratio | 1.45 |
| Debt / Equity | undefined |
| Debt / EBITDA | - |
| Debt / FCF | - |
| Interest Coverage | undefined |
Financial Efficiency
Return on Equity is -0.62% and Return on Invested Capital is -39.35%.
| Return on Equity | -0.62% |
| Return on Assets | -0.34% |
| Return on Invested Capital | -39.35% |
| Revenue Per Employee | $190.5K |
| Profits Per Employee | $-35.81K |
| Employee Count | 116 |
| Asset Turnover | 1.79 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 716K |
| Effective Tax Rate | -0.21% |
Stock Price Statistics
The stock price has increased by -20.06% in the last 52 weeks. The beta is 0.67, so Psychemedics's price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | -20.06% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.34 |
| Relative Strength Index (RSI) | 47.19 |
| Average Volume (20 Days) | 42.86K |
Income Statement
In the last 12 months, Psychemedics had revenue of 22.1M and earned -4.15M in profits. Earnings per share was -0.72.
| Revenue | 22.1M |
| Gross Profit | 8.41M |
| Operating Income | -2.92M |
| Net Income | -4.15M |
| EBITDA | -251K |
| EBIT | -2.92M |
| Earnings Per Share (EPS) | -0.72 |
Balance Sheet
The company has 1.96M in cash and 2.3M in debt, giving a net cash position of -334K.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.3M |
| Net Cash | -334K |
| Retained Earnings | -16.77M |
| Total Assets | 9.84M |
| Working Capital | 2.25M |
Cash Flow
In the last 12 months, operating cash flow was -1.48M and capital expenditures -157K, giving a free cash flow of -1.64M.
| Operating Cash Flow | -1.48M |
| Capital Expenditures | -157K |
| Free Cash Flow | -1.64M |
| FCF Per Share | -0.29 |
Margins
Gross margin is 38.07%, with operating and profit margins of -13.22% and -18.8%.
| Gross Margin | 38.07% |
| Operating Margin | -13.22% |
| Pretax Margin | -15.56% |
| Profit Margin | -18.8% |
| EBITDA Margin | -1.14% |
| EBIT Margin | -13.22% |
| FCF Margin | -7.41% |
Dividends & Yields
PMD pays an annual dividend of $0.14, which amounts to a dividend yield of 5.24%.
| Dividend Per Share | $0.14 |
| Dividend Yield | 5.24% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -27.45% |
| Earnings Yield | -26.97% |
| FCF Yield | -10.4% |
Analyst Forecast
Currently there are no analyst rating for PMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 1, 2002. It was a backward split with a ratio of 1:4.
| Last Split Date | Aug 1, 2002 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 6 |